The company’s U.S. division said in a news release there have been 26 cases of suspected malfunctions. There have been no deaths.
Patients have described symptoms of “underlying hypersensitivity reaction,” Sanofi said.
“We’re doing this voluntary recall as a precaution,” said Dr. Paul Chew, global chief medical officer for Sanofi, “and we have temporarily stopped manufacturing.”
Chew advised people who have one of the recalled epinephrine pens to call their doctors and get a prescription for a new and different auto-injector.
Customers can call 1-866-726-6340 to get information on how to return their pens and get a refund or costs from a new pen purchase.
The website is www.Auvi-Q.com.
